Varian, Inc. recently introduced its ProSEC 300S, a new size exclusion chromatography column designed for the accurate and precise analysis of globular proteins in the pharmaceutical and bioscience industries.
Protein characterisation by size exclusion chromatography is an extremely important application. The need for it is expanding rapidly as protein-based pharmaceuticals continue to grow as a share of total compounds under development. The characteristics of ProSEC columns were designed to address specific current challenges in this area, including low recoveries and inconsistent results. ProSEC 300S uses the latest developments in silica technology for superior column to column and batch to batch reproducibility, so the analyst can expect the best results time after time.
The special surface technology of ProSEC columns reduces protein interactions, resulting in high sample recovery and reliable analysis of a wide range of globular proteins. High mechanical stability results in excellent column lifetimes and allows high sample throughput.
"ProSEC 300S provides consistent results for the pharmaceutical industry in high performance SEC," said Martin O'Donoghue, SVP, Scientific Instruments, Varian, Inc. "Researchers doing protein analyses can have confidence in the performance of the ProSEC column and the customer support that Varian offers."
ProSEC is one of a comprehensive range of size exclusion and gel permeation columns, standards and instruments from Varian, all designed for optimum performance and reliability even under the most severe operating conditions.
Source: Varian Inc.